Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Study of GQ1010 in Subjects With Advanced Solid Tumors
- Conditions
- Advanced Malignant Solid Tumors
- Interventions
- Drug: Dose Expansion1Drug: Dose Expansion3Drug: Dose EscalationDrug: phase IIDrug: Dose Expansion2
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- GeneQuantum Healthcare (Suzhou) Co., Ltd.
- Target Recruit Count
- 260
- Registration Number
- NCT06464055
- Locations
- 🇨🇳
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China
🇨🇳Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China
🇨🇳Tianjin medical university cancer institute & hospital, Tianjin, China
A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors
- Conditions
- HER2 Expressing or Mutated Advanced Malignant Solid Tumors
- Interventions
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- GeneQuantum Healthcare (Suzhou) Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06154343
- Locations
- 🇨🇳
Chinese PLA general hospital, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳Fujian Cancer Hospital, Fuzhou, Fujian, China
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
- Conditions
- HER2-positive Biliary Tract CancerHER2-Positive Salivary Gland CarcinomasHER2-positive Breast CancerHER2-Positive Advanced Solid Tumor
- Interventions
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- GeneQuantum Healthcare (Suzhou) Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT04450732
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
🇦🇺Scientia Clinical Research Limited, Randwick, New South Wales, Australia
🇦🇺Cabrini Institute in Melbourne, Australia, Melbourne, Victoria, Australia